Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : CHX
Therapeutic Area : Undisclosed
Study Phase : Phase I
Recipient : University of Santiago de Compostela
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : CHX is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
May 31, 2024
Lead Product(s) : CHX
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Recipient : University of Santiago de Compostela
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Carvacrol
Therapeutic Area : Dental and Oral Health
Study Phase : Phase I
Recipient : University of Santiago de Compostela
Deal Size : Inapplicable
Deal Type : Inapplicable
Short-Term Anti-plaque Effect of Cymenol Mouthwash Analysed Using Dentius Deep Plaque Software
Details : Cymenol is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Dental Plaque.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 30, 2022
Lead Product(s) : Carvacrol
Therapeutic Area : Dental and Oral Health
Highest Development Status : Phase I
Recipient : University of Santiago de Compostela
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
